Transcutaneous Measurement of Jaundice in the Newborn
TcBili
Comparison of Transcutaneous or Laboratory Measurement of Bilirubin in the Newborn
1 other identifier
observational
1,000
1 country
1
Brief Summary
Prospective comparison of measurement of bilirubin in jaundiced newborns by a transcutaneous device (bilirubinometer) and laboratory analysis of blood samples. We hypothesise that correlation of the two measurements depend on bilirubin level, gestational age as well as postnatal age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 23, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedMarch 28, 2017
March 1, 2017
2.8 years
July 23, 2010
March 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of transcutaneous bilirubin (skin color, TcB) and bilirubin measured in a blood sample (TsB)
To have statistical strength for comparison of the two tests between 1500 and 2000 patients are needed
12 months
Secondary Outcomes (1)
Differences in TcB measured at the forehead or at the sternum
12 months
Study Arms (1)
Neonatal jaundice
Infants born between July 1st 2010 and July 31st 2010 and admitted to normal newborn nursery
Interventions
Blood sampling and analysis, measurement of skin color by transcutaneous bilirubinometry
Eligibility Criteria
Newborn infants admitted to normal newborn nursery
You may qualify if:
- Newborn infant admitted to normal newborn nursery
You may not qualify if:
- Informed consent not obtained
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Olavs University Hospital
Trondheim, N-7006, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vibeke Videm, MD, PhD
Norwegian University of Science and Technology, Instititue director
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2010
First Posted
July 26, 2010
Study Start
July 1, 2010
Primary Completion
April 1, 2013
Study Completion
October 1, 2013
Last Updated
March 28, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share